MEREDITH STOCKLIN: Open Payments
NPI 1891414660 · LUMBERTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,657 in 64 payments from 13 companies in 2025. Trend: 2023 $3,307 · 2024 $2,076 · 2025 $1,657
Food & beverage: $1,657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $361 |
| AstraZeneca Pharmaceuticals LP | 6 | $292 |
| Novo Nordisk Inc | 13 | $215 |
| Amgen Inc. | 6 | $198 |
| Merck Sharp & Dohme LLC | 3 | $148 |
| Madrigal Pharmaceuticals | 1 | $141 |
| Lilly USA, LLC | 6 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| PFIZER INC. | 2 | $34 |
| Exact Sciences Corporation | 2 | $30 |
Products named: QULIPTA, OTEZLA, REZDIFFRA, BREZTRI, AIRSUPRA, CAPVAXIVE, Ozempic, REXULTI.
Industry payments across NJ — which companies pay providers there.
